Estee Lauder Companies Inc vs MakeMyTrip Ltd — how do they compare? Estee Lauder Companies Inc trades at $98.05 (market cap $34.17B), while MakeMyTrip Ltd trades at $44.73 (market cap $4.09B). The key difference: Estee Lauder Companies Inc is far larger — about 8.4× MakeMyTrip Ltd's market cap, and Estee Lauder Companies Inc pays a 1.48% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Estee Lauder Companies Inc for 122 Days and MakeMyTrip Ltd for 12 Days on average.
| EL | MMYT | |
|---|---|---|
Market Cap | $34.17B | $4.09B |
Volume | 3,921,497 | 1,828,010 |
Sector | Consumer Staples | Consumer Cyclical |
52-Week High | $119.61 | $92.25 |
52-Week Low | $67.23 | $36.30 |
Typical Hold Time | 122 Days | 12 Days |
Enterprise Value | $39.92B | $4.75B |
Dividend Yield | 1.48% | — |
Signals from Pluang's Aura AI — not financial advice
EL trades at $94.32, down 0.14% on the day, with a neutral technical signal. The stock has beaten earnings estimates for the last three quarters, though annual revenue declined to $14.33B in 2025 with a net loss of $1.13B. Analyst consensus is a Buy with a $103.00 price target, and recent news highlights strategic partnerships in AI and leadership appointments aimed at strengthening brand strategy.
The outlook is cautiously optimistic, supported by earnings beats and positive analyst sentiment, but risks include sustained profitability challenges, high debt levels, and competitive pressures. Upside potential exists if margin improvements and strategic initiatives translate to earnings growth, yet investors must monitor execution on turnaround efforts.
MakeMyTrip (MMYT) trades at $43.53, up 0.28% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported mixed quarterly earnings, with a Q1 2026 beat and Q4 2025 and Q2 2026 misses. Revenue grew to $978.34M in 2025, but net income margin compressed to 3.23% in 2026. Analyst consensus is strongly bullish with a $77.00 price target, though institutional selling has been noted recently.
The outlook is bifurcated: strong analyst support and a potential Indian listing offer upside, but declining profitability, high P/E ratio, and bearish technicals pose risks. Investors face volatility from operational execution and travel industry cyclicality against a backdrop of Wall Street optimism.
Trailing returns across standard periods
Latest headlines on both assets
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →